Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Clinical trial NCT00604721 · COMPLETED

Trial details

NCT number: NCT00604721
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2007-11-01
Primary completion: 2012-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.